- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Taiwanese Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
13
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
13 companies
Orient Pharma
Market Cap: NT$5.5b
Engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally.
4166
NT$24.50
7D
-0.2%
1Y
-29.5%
Maxigen Biotech
Market Cap: NT$3.6b
Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.
1783
NT$44.40
7D
7.0%
1Y
6.0%
Savior Lifetec
Market Cap: NT$5.9b
A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.
4167
NT$18.55
7D
3.6%
1Y
-9.1%
TCM Biotech International
Market Cap: NT$10.6b
A biotech company, engages in the research and development of drugs for liver diseases.
4169
NT$180.00
7D
-2.2%
1Y
201.0%
Syngen BiotechLtd
Market Cap: NT$3.5b
Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.
8279
NT$130.00
7D
-1.5%
1Y
0%
Panion & Bf Biotech
Market Cap: NT$5.8b
A biotechnology pharmaceutical company, provides western medicines, cosmetics, and health care products in Taiwan, the United States, China, Hong Kong, and internationally.
1760
NT$67.60
7D
6.0%
1Y
-25.7%
Sunmax Biotechnology
Market Cap: NT$21.5b
A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.
4728
NT$394.50
7D
0.9%
1Y
44.2%
Nang Kuang Pharmaceutical
Market Cap: NT$3.9b
Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.
1752
NT$38.60
7D
-0.5%
1Y
-9.6%
Synmosa Biopharma
Market Cap: NT$16.5b
A specialty pharmaceutical company, researches, develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand in Taiwan.
4114
NT$32.90
7D
-0.3%
1Y
3.1%
PharmaEngine
Market Cap: NT$10.3b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$72.00
7D
5.9%
1Y
-27.9%
Ever Supreme Bio Technology
Market Cap: NT$14.5b
Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.
6712
NT$165.00
7D
3.4%
1Y
4.0%
Standard Chemical & Pharmaceutical
Market Cap: NT$10.8b
Manufactures and sells pharmaceutical products in Taiwan and internationally.
1720
NT$60.60
7D
6.7%
1Y
-4.3%
TTY Biopharm
Market Cap: NT$19.6b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$78.90
7D
-0.5%
1Y
8.4%